Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella surface antigens are a complex array of molecules on the bacterial cell wall that determine the serological identity and virulence of Salmonella species (Source: CDC, 2022). These antigens are traditionally classified into three types: the somatic O-antigen (part of the lipopolysaccharide layer), the flagellar H-antigen (composed of flagellin proteins), and the capsular Vi-antigen found primarily in Salmonella Typhi (Source: StatPearls, 2023). The O-antigen is crucial for structural integrity and protecting the bacterium from the host's complement-mediated killing, while the H-antigen facilitates motility and invasion of host cells (Source: UniProt, 2024). The Vi-antigen acts as a protective shield, preventing antibody binding and phagocytosis, thereby enhancing the systemic spread of the pathogen (Source: PubMed, PMID: 28533306). These surface components are the primary targets for both diagnostic serotyping via the Kauffmann-White scheme and for preventive vaccines (Source: WHO, 2023). Current vaccines, such as the Vi capsular polysaccharide and the live-attenuated Ty21a strain, work by inducing protective immune responses against these specific surface structures to prevent diseases like typhoid fever and salmonellosis.
Active immunization through the induction of humoral and cellular immune responses against bacterial surface components to prevent host cell attachment and invasion; or direct binding and neutralization of lipopolysaccharide components to mitigate endotoxicity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella surface antigen.